Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KPTI

Karyopharm Therapeutics Inc

May 08 • 04:00PM ET

8.64

-0.21 -2.37 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: BDTX NUVB JANX ATRA FENC

| Held by: VTI VXF IWC PRFZ TMED BTEC CHNA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-16.62	Insider Own	7.72%	Shs Outstand	22.54M	Perf Week	-1.48%
Market Cap	194.77M	Forward P/E	-	EPS next Y	-3.05	Insider Trans	-1.34%	Shs Float	20.89M	Perf Month	5.88%
Enterprise Value	364.64M	PEG	-	EPS next Q	-1.42	Inst Own	67.20%	Short Float	27.37%	Perf Quarter	38.02%
Income	-196.04M	P/S	1.33	EPS this Y	75.95%	Inst Trans	37.04%	Short Ratio	5.76	Perf Half Y	61.19%
Sales	146.07M	P/B	-	EPS next Y	29.22%	ROA	-139.10%	Short Interest	5.72M	Perf YTD	17.39%
Book/sh	-16.00	P/C	3.06	EPS next 5Y	54.33%	ROE	-	52W High	10.99 -21.38%	Perf Year	40.49%
Cash/sh	2.83	P/FCF	-	EPS past 3/5Y	16.03% 15.19%	ROIC	-	52W Low	3.65 136.69%	Perf 3Y	-76.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.39% 6.21%	Gross Margin	95.72%	Volatility	5.81% 6.71%	Perf 5Y	-93.14%
Dividend TTM	-	EV/Sales	2.50	EPS Y/Y TTM	-76.41%	Oper. Margin	-62.10%	ATR (14)	0.60	Perf 10Y	-92.70%
Dividend Ex-Date	-	Quick Ratio	1.08	Sales Y/Y TTM	0.57%	Profit Margin	-134.21%	RSI (14)	52.76	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	1.12	EPS Q/Q	-55.63%	SMA20	-1.59%	Beta	0.81	Target Price	14.71
Payout	-	Debt/Eq	-	Sales Q/Q	11.58%	SMA50	7.93%	Rel Volume	0.30	Prev Close	8.85
Employees	228	LT Debt/Eq	-	Earnings	May 14 BMO	SMA200	27.57%	Avg Volume	993.45K	Price	8.64
IPO	Nov 06, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	-186.32% -2.92%	Trades		Volume	294,573	Change	-2.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)